Evidence map›Paper›PMID 29247283›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'.

Ana M Denis-Bacelar, Sarah J Chittenden, David P Dearnaley, Antigoni Divoli, Joe M O'Sullivan, V Ralph McCready, Bernadette Johnson, Yong Du, Glenn D Flux

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Ana M Denis-BacelarChemical, Medical and Environmental Science Department, National Physical Laboratory, Hampton Road, Teddington, TW11 0LW, UK. ana.denisbacelar@npl.co.uk.ORCID 0000-0002-0008-1598
Sarah J ChittendenJoint Department of Physics, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, SM2 5NG, UK.
David P DearnaleyDivision of Radiotherapy and Imaging, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, SM2 5NG, UK.
Antigoni DivoliJoint Department of Physics, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, SM2 5NG, UK.
Joe M O'SullivanCentre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, BT7 1NN, UK.
V Ralph McCreadyDepartment of Nuclear Medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, BN2 5BE, UK.
Bernadette JohnsonDivision of Radiotherapy and Imaging, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, SM2 5NG, UK.
Yong DuDepartment of Nuclear Medicine and PET/CT, The Royal Marsden NHS Foundation Trust, London, SM2 5PT, UK.
Glenn D FluxJoint Department of Physics, The Institute of Cancer Research and The Royal Marsden Hospital NHS Foundation Trust, London, SM2 5NG, UK.

Funding

Cancer Research UK 10588Cancer Research UK 12518Cancer Research UK 19727
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bone and BonesRadioimmunotherapyRadioisotopesRadioisotopes

Identifiers

PMID29247283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.